Victory Capital Management
XBIT icon

Victory Capital Management’s XBiotech XBIT Stock Holding History

Victory Capital Management’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-2,698
Closed -$28K – 3303
2020
Q1 		$28K Buy
+2,698
New +$43.9K ﹤0.01% 2990
2019
Q4 		– Sell
-3,393
Closed -$35K – 3296
2019
Q3 		$35K Buy
+3,393
New +$27.6K ﹤0.01% 2839

Other funds holding XBIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Victory Capital Management's XBIT Position: Q2 2020 in Review

Victory Capital Management sold out of XBiotech (XBIT) in Q2 2020, closing a stake of 2,698 shares — an estimated $28K sold.

Victory Capital Management first reported a position in XBIT in Q3 2019 and held it in 2 quarters. The position peaked at $35K in Q3 2019. 65 funds tracked by Wall St. Rank hold XBIT as of Q2 2020.

  • Victory Capital Management reported no remaining XBiotech position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 2,698 XBiotech shares in Q2 2020, an estimated $28K.
  • Victory Capital Management first reported a position in XBiotech in Q3 2019 and held it in 2 quarters.
  • Victory Capital Management's XBiotech position peaked at $35K in Q3 2019.
  • 65 funds tracked by Wall St. Rank held XBiotech as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.